141 related articles for article (PubMed ID: 31152910)
21. Molecular biology of the hepatitis B virus and role of the X gene.
Wei Y; Neuveut C; Tiollais P; Buendia MA
Pathol Biol (Paris); 2010 Aug; 58(4):267-72. PubMed ID: 20483545
[TBL] [Abstract][Full Text] [Related]
22. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
23. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
Joo HY; Han KH; Ryu WS
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
25. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
26. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
27. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
[TBL] [Abstract][Full Text] [Related]
29. Molecular virology of hepatitis B virus and targets for antiviral intervention.
Glebe D; König A
Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
[TBL] [Abstract][Full Text] [Related]
30. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
31. [Interaction of retroviruses and oncogenes with the cellular genome. 1].
Scherdin U; Hölzel F
Arzneimittelforschung; 1987 Oct; 37(10):1205-9. PubMed ID: 2829931
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.
Zhang Z; Protzer U; Hu Z; Jacob J; Liang TJ
J Virol; 2004 May; 78(9):4566-72. PubMed ID: 15078938
[TBL] [Abstract][Full Text] [Related]
33. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
34. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
35. Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
Deng L; Gan X; Ito M; Chen M; Aly HH; Matsui C; Abe T; Watashi K; Wakita T; Suzuki T; Okamoto T; Matsuura Y; Mizokami M; Shoji I; Hotta H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567989
[TBL] [Abstract][Full Text] [Related]
36. C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis.
Quetier I; Brezillon N; Revaud J; Ahodantin J; DaSilva L; Soussan P; Kremsdorf D
J Gen Virol; 2015 Mar; 96(Pt 3):614-625. PubMed ID: 25519169
[TBL] [Abstract][Full Text] [Related]
37. Cancer genes: rare recombinants instead of activated oncogenes (a review).
Duesberg PH
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2117-24. PubMed ID: 3550807
[TBL] [Abstract][Full Text] [Related]
38. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.
Robinson WS
Annu Rev Med; 1994; 45():297-323. PubMed ID: 8198385
[TBL] [Abstract][Full Text] [Related]
39. Retroviral transforming genes in normal cells?
Duesberg PH
Nature; 1983 Jul 21-27; 304(5923):219-26. PubMed ID: 6346107
[TBL] [Abstract][Full Text] [Related]
40. Oncogenesis and transforming viruses: the hepatitis B virus and hepatocellularcarcinoma--the etiopathogenic link.
Lee AT; Lee CG
Front Biosci; 2007 Jan; 12():234-45. PubMed ID: 17127296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
